Cell Microsystems
Durham
About Cell Microsystems
Cell Microsystems is an early-growth stage company that develops, manufactures, and markets innovative products for single-cell biology. The company’s proprietary CellRaft™ Technology enables high-efficiency sorting and isolation of single cells under standard culture conditions resulting in unperturbed phenotypes and high viability. Coupled with the company’s automated imaging platform, a user can select a cell in real time and ‘track and trace’ that cell through imaging, collection, and downstream analysis. By sorting during real-time imaging, no cells are wasted enabling single-cell isolation from even small, precious samples. The CellRaft Technology offers scalable solutions making cell separation technology available for every lab.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $30.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2023)
- Website: cellmicrosystems.com
- Phone: 252 285 9842
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/cell-microsystems-39461 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.